5.2 Serum Protein Electrophoresis (SPEP), Immunofixation & Monoclonal Gammopathies

5.2 Serum Protein Electrophoresis (SPEP), Immunofixation & Monoclonal Gammopathies

[!NOTE] ASCP C Exam Context: Electrophoretic analysis of serum and body fluid proteins is a vital competency evaluated on the ASCP Chemistry examination. Technologists must understand buffer ionization at pH 8.6, the physics of electroendosmosis, the specific protein markers within each electrophoretic zone, the densitometric patterns characteristic of plasma cell dyscrasias and organ failures, immunofixation confirmation, and CSF oligoclonal band evaluation.

Electrophoresis is the physical separation of charged solute particles dissolved or suspended in an electrolyte buffer under the influence of an applied electrical field. In the clinical chemistry laboratory, Serum Protein Electrophoresis (SPEP) serves as the primary screening methodology for detecting, characterizing, and monitoring monoclonal gammopathies (multiple myeloma, Waldenström macroglobulinemia, MGUS), immune deficiencies, protein-losing enteropathies, nephrotic syndromes, and hereditary protein deficiencies.

---

Principles of Zone and Capillary Electrophoresis

The velocity of migration ($v$) of a charged macromolecule in an electrical field is governed by the balance between electrical driving force and hydrodynamic frictional resistance, formalized by the electrophoretic mobility ($\mu$) equation:

$\mu = \frac{v}{E} = \frac{Q}{6 \pi \eta r}$

where $E$ is electrical field strength (V/cm), $Q$ is the net electrical charge of the hydrated molecule, $\eta$ is buffer viscosity, and $r$ is the effective Stokes ionic radius of the hydrated protein. Electrophoretic mobility is therefore directly proportional to net surface charge ($Q$) and inversely proportional to molecular size and buffer viscosity ($6 \pi \eta r$).

SPEP Analytical Setup & Physicochemical Conditions
├── Support Medium: Agarose gel (standard clinical matrix) or fused-silica capillary (Capillary Zone Electrophoresis [CZE])
├── Buffer System: Barbital (veronal) or Tris-barbital buffer standardized to pH 8.6, ionic strength 0.05 to 0.10 mol/L
├── Polarity & Migration: Anode (+) at positive terminal; Cathode (-) at negative terminal
└── Charge Dynamics: At pH 8.6, all serum proteins exceed their pI (pI 4.0 to 7.3) -> Net Negative Charge -> Migrate toward Anode (+)

The Mechanism of Electroendosmosis (Endosmotic Flow)

Under standard alkaline electrophoresis conditions on solid support media (agarose gel or cellulose acetate), an opposing physical force known as electroendosmosis (endosmosis) exerts a profound influence on final band positions:

1. Fixed Negative Matrix Charges: Solid support matrices contain structural chemical impurities possessing fixed, ionized negative charges (e.g., carboxylate [$-COO^-$] and sulfate [$-SO_4^{2-}$] groups in agarose).
2. Mobile Hydronium Ion Layer: In contact with alkaline buffer, these fixed immobilized negative surface charges attract a mobile counter-ion sheath composed of positively charged hydronium ions ($H_3O^+$).
3. Cathodic Solvent Drag: When an electrical potential is applied across the gel, the mobile $H_3O^+$ cations are drawn toward the negative cathode (-). This bulk migration of hydrated solvent molecules creates a powerful cathodic convective solvent flow running counter to the anodal electrophoretic migration of proteins.
4. Gamma Retardation and Position: Proteins with high net negative charge and small hydrodynamic radii (e.g., albumin) possess anodal electrophoretic mobility that easily overcomes this solvent drag and race toward the anode. By contrast, gamma globulins (IgG) carry very low net negative charges at pH 8.6 ($pI \approx 6.8\text{--}7.3$). The cathodic endosmotic solvent drag exceeds their weak anodal electrophoretic drive, sweeping them backward past the point of sample application toward the cathode (-).

Electroendosmotic Solvent Flow vs. Anodal Electrophoretic Drive

  Cathode (-)                                                  Anode (+)
  ═══════════════════════════════════════════════════════════════════════
                 ◄─────── Bulk Solvent Flow (H3O+) ───────
                         (Electroendosmosis)

                 ───────► Protein Electrophoretic Drive ───────►
                         (Proportional to Net Negative Charge)

  [ Gamma Zone ]      [ Beta ]      [ Alpha-2 ]      [ Alpha-1 ]   [ Albumin ]
  (Endosmosis         (Moderate      (High            (Very High    (Maximum Net
   Dominates)          Charge)        Charge)          Charge)       Charge)

Modern Analytical Platforms: Agarose Gel vs. Capillary Electrophoresis

• Agarose Gel Electrophoresis (AGE): Standard clinical matrix providing excellent resolution, clear background, and low endosmosis compared to historical cellulose acetate. Following separation, gels are fixed in acid-alcohol, stained with protein dyes (Amido Black 10B, Coomassie Brilliant Blue, or Ponceau S), cleared, dried, and scanned via a transmission densitometer at 540 to 600 nm to convert stained bands into quantitative integration peaks.
• Capillary Zone Electrophoresis (CZE): Fully automated platform utilizing narrow fused-silica capillaries (25 to 75 $\mu$m internal diameter) filled with alkaline buffer. High voltages (up to 10,000 V) produce rapid separations with efficient Joule heat dissipation. Proteins are detected directly on-column via their intrinsic peptide bond ultraviolet absorbance at 200 to 214 nm, eliminating dye-binding artifacts and manual staining steps.

---

The Five Canonical SPEP Fractions and Their Clinical Constituents

Standard serum protein electrophoresis separates normal human serum into five primary zones, listed below in order of migration from the positive anode (+) to the negative cathode (-):

Densitometric Normal SPEP Fraction Layout (Anode to Cathode)

  Absorbance
      │           Albumin (55 - 65%)
      │              ┌─┐
      │              │ │
      │              │ │
      │              │ │
      │              │ │
      │              │ │                      Gamma (11 - 22%)
      │              │ │     Alpha-2   Beta        ┌───┐
      │              │ │     (7-13%)  (9-15%)     │   │
      │              │ │Alpha-1 ┌─┐    ┌─┐       │     │
      │              │ │ (2-4%) │ │    │ │      │       │
      └──────────────┴─┴───▲────┴─┴────┴─┴─────┴─────────┴─────
      (+) Anode                                     Cathode (-)

1. Albumin Fraction (55% to 65% of Total Protein; 3.5 to 5.0 g/dL)

• Characteristics: Migrates most anodally due to highest net negative charge ($pI \approx 4.7$); forms a single, tall, narrow, symmetrical peak that serves as the internal calibrator and baseline reference for the densitometric scan.
• Bisalbuminemia: A rare benign genetic condition (or temporary finding following high-dose beta-lactam antibiotic therapy or pancreatic pseudocyst leakage) in which two distinct albumin peaks appear side-by-side due to heterozygous synthesis of a mutated albumin with altered surface charge.

2. Alpha-1 ($\alpha_1$) Globulin Fraction (2% to 4% of Total Protein; 0.1 to 0.3 g/dL)

• Alpha-1-Antitrypsin (AAT): Comprises >90% of the entire alpha-1 band. AAT is a 52 kDa glycoprotein functioning as a serine protease inhibitor (SERPIN). Its primary physiological role is neutralizing neutrophil elastase in pulmonary alveolar walls, protecting lung parenchyma from proteolytic destruction during phagocytic responses. It is a positive acute-phase reactant.
  • Clinical Pathology: Congenital AAT deficiency (autosomal codominant, homozygous PiZZ genotype) prevents hepatic secretion of AAT, leading to intracellular polymerization. It causes juvenile hepatitis, neonatal cholestatic jaundice, and childhood liver cirrhosis, as well as early-onset panacinar pulmonary emphysema in young adults (accelerated by tobacco smoke exposure). On SPEP, AAT deficiency manifests as a severe flattening or complete absence of the alpha-1 band.
• Alpha-1-Acid Glycoprotein (AAG / Orosomucoid): A heavily glycosylated (45% carbohydrate) acute-phase protein that binds basic, lipophilic drugs (e.g., lidocaine, propranolol, quinidine).

3. Alpha-2 ($\alpha_2$) Globulin Fraction (7% to 13% of Total Protein; 0.6 to 1.0 g/dL)

• Haptoglobin (Hp): An alpha-2 glycoprotein (MW 85 to 400 kDa) that binds free hemoglobin dimers ($Hb\cdot\alpha\beta$) released during intravascular hemolysis with stoichiometric irreversibility. The resulting large Hb-Hp complex is rapidly cleared by CD163 scavenger receptors on splenic and hepatic reticuloendothelial macrophages, preventing free hemoglobin from filtering through glomeruli and causing acute tubular injury. Haptoglobin is depleted in hemolytic states and elevated during acute inflammation.
• Alpha-2-Macroglobulin (AMG): A massive tetrameric protease inhibitor (MW 720 kDa) that inhibits a broad spectrum of endoproteases (trypsin, thrombin, plasmin, elastase). Synthesized by hepatocytes, AMG cannot cross glomerular capillary basement membranes due to its extreme size. In nephrotic syndrome, glomerular pores enlarge, allowing albumin and smaller proteins to escape, while liver protein synthesis is compensatorily stimulated. AMG is retained in circulation, causing a dramatic 5- to 10-fold elevation that produces a towering alpha-2 peak.
• Ceruloplasmin: A 132 kDa blue copper-binding glycoprotein carrying >95% of circulating plasma copper. Synthesized in the liver, it exhibits ferroxidase activity, catalyzing the oxidation of toxic ferrous iron ($Fe^{2+}$) to ferric iron ($Fe^{3+}$), allowing iron to bind apotransferrin. Circulating ceruloplasmin is decreased in Wilson's disease (hepatolenticular degeneration, mutation in the $ATP7B$ copper-transporting ATPase gene), leading to toxic copper deposition in hepatocytes, basal ganglia, and cornea (Kayser-Fleischer rings).

4. Beta ($\beta$) Globulin Fraction (9% to 15% of Total Protein; 0.7 to 1.2 g/dL)

High-resolution electrophoresis and capillary systems resolve the beta region into two distinct sub-bands:

• Beta-1 ($\beta_1$) Sub-band — Transferrin: The primary ferric iron ($Fe^{3+}$) transport glycoprotein (MW 77 kDa). Transferrin synthesis is up-regulated in iron deficiency anemia, producing an elevated, prominent beta-1 peak. Transferrin drops in protein malnutrition, nephrotic loss, and chronic inflammation.
• Beta-2 ($\beta_2$) Sub-band — Complement C3 and Beta-2-Microglobulin:
  • Complement C3: The central convergence component of the complement cascade. C3 is an acute-phase reactant. In stored or thawed serum, C3 spontaneously cleaves into smaller fragments (C3c) that migrate more anodally toward beta-1, causing loss of the split-beta pattern.
  • Beta-2-Microglobulin ($\beta_2\text{M}$): The 11.8 kDa light chain of MHC Class I molecules. Elevated circulating levels serve as an independent prognostic tumor burden marker in multiple myeloma and chronic lymphocytic leukemia.
• Fibrinogen Artifact in Plasma: If plasma containing EDTA or heparin is electrophoresed instead of serum, fibrinogen (MW 340 kDa) forms a sharp, distinct, discrete band at the beta-gamma junction. This band closely mimics a monoclonal paraprotein spike, prompting unnecessary clinical workup. Technologists must verify whether the sample clotted or inspect for a fibrin clot before confirming a paraprotein.

5. Gamma ($\gamma$) Globulin Fraction (11% to 22% of Total Protein; 0.8 to 1.6 g/dL)

• Immunoglobulins: Composed of polyclonal antibodies synthesized and secreted by mature plasma cells and differentiated B-lymphocytes: IgG (~80%), IgA (~15%), IgM (~5%), IgD (<1%), and IgE (<0.01%).
• Under normal conditions, thousands of diverse plasma cell clones secrete antibodies with distinct hypervariable sequences and surface charges, yielding a broad, smooth, heterogeneous, dome-shaped Gaussian distribution occupying the cathodic region of the electrophoretogram.

---

Classic SPEP Pathological Patterns

Clinical chemistry technologists must immediately recognize seven classic pathological densitometric patterns:

Classic Pathological SPEP Patterns
├── Monoclonal Gammopathy: Tall, narrow, discrete spike (base <= albumin base) in gamma, beta, or alpha-2
├── Polyclonal Gammopathy: Broad, diffuse, dome-shaped elevation across the entire gamma zone
├── Cirrhosis / Beta-Gamma Bridging: Polyclonal IgA bridges beta and gamma peaks, obliterating the valley
├── Nephrotic Syndrome: Collapsed albumin peak with massive selective retention of Alpha-2-Macroglobulin
├── Acute-Phase Reactant: Decreased Albumin with dramatic increases in Alpha-1 (AAT) and Alpha-2 (Haptoglobin)
├── Alpha-1-Antitrypsin Deficiency: Complete flattening or absence of the Alpha-1 globulin band
└── Hypogammaglobulinemia: Near-total absence or severe depression of the cathodic gamma zone

Visual Densitometric Comparison of Pathological SPEP Patterns

1. Monoclonal Spike (M-Spike)      2. Beta-Gamma Bridging (Cirrhosis)
      Albumin                           Albumin
        ┌─┐                               ┌─┐
        │ │        M-Spike                │ │
        │ │          ┌─┐                  │ │
        │ │          │ │                  │ │     Beta-Gamma
        │ │  a1 a2 b │ │                  │ │ a1 a2 Bridge
       ─┴─┴──▲──▲──▲─┴─┴─                ─┴─┴─▲──▲───█████───
       (+)            (-)                (+)              (-)

3. Nephrotic Syndrome              4. Acute Phase Reactant Pattern
             Alpha-2                          Albumin
              ┌───┐                             ┌─┐
              │   │                             │ │   Alpha-2
      Albumin │   │                             │ │    ┌─┐
        ┌─┐   │   │                             │ │ a1 │ │
        │ │ a1│   │ b  g                        │ │┌─┐ │ │ b   g
       ─┴─┴─▲─┴───┴─▲──▲─                      ─┴─┴┴─┴─┴─┴─▲───▲─
       (+)            (-)                      (+)            (-)

1. Monoclonal Gammopathy (M-Spike / Paraproteinemia)

• Densitometric Appearance: A tall, narrow, sharply defined spike possessing a base width equal to or narrower than that of the albumin peak. While most commonly located in the gamma region, monoclonal spikes may appear in the beta or alpha-2 regions (especially IgA monoclonal proteins, which migrate faster anodally due to higher sialic acid content).
• Pathophysiology: Uncontrolled clonal proliferation of a single transformed plasma cell or B-cell clone producing identical immunoglobulin molecules possessing identical heavy-chain and light-chain structures.
• Clinical Differentials:
  • Multiple Myeloma (MM): Malignant plasma cell neoplasm. Paraprotein distribution: IgG (~60%), IgA (~20%), Light Chain only (Bence Jones myeloma, ~15%), IgD (<1%), IgE (extremely rare). Diagnostic criteria include $\ge 10%$ clonal bone marrow plasma cells and CRAB end-organ damage (hyperCalcemia, Renal insufficiency, Anemia, lytic Bone lesions).
  • Waldenström Macroglobulinemia (WM): Clonal lymphoplasmacytic lymphoma characterized by a large monoclonal IgM spike. Because pentameric IgM (MW 900 kDa) remains largely intravascular, it induces serum hyperviscosity syndrome (visual loss, retinal vein engorgement, mucosal bleeding, headache, ataxia).
  • Monoclonal Gammopathy of Undetermined Significance (MGUS): Asymptomatic premalignant state; serum M-protein < 3.0 g/dL, bone marrow clonal plasma cells < 10%, and complete absence of CRAB features. Risk of progression to multiple myeloma is ~1% per year.
  • Smoldering Multiple Myeloma (SMM): Serum M-protein $\ge 3.0$ g/dL and/or 10% to 60% bone marrow plasma cells, but lacking CRAB criteria.

2. Polyclonal Hypergammaglobulinemia

• Densitometric Appearance: A broad, diffuse, asymmetrical, dome-shaped elevation spanning the entire gamma region without discrete localized banding.
• Pathophysiology: Heterogeneous stimulation of thousands of diverse plasma cell clones producing a wide assortment of immunoglobulins.
• Clinical Differentials: Chronic active systemic infections (tuberculosis, osteomyelitis, viral hepatitis, HIV infection), autoimmune connective tissue diseases (Systemic Lupus Erythematosus [SLE], Rheumatoid Arthritis, Sjögren's syndrome, Hashimoto's thyroiditis), and sarcoidosis.

3. Cirrhosis with Beta-Gamma Bridging

• Densitometric Appearance: Profound depression of the albumin peak accompanied by a massive, slurred polyclonal elevation that completely obliterates the baseline valley (trough) between the beta and gamma fractions.
• Pathophysiology: Severe chronic hepatocellular destruction (e.g., alcoholic liver cirrhosis, advanced hepatitis C) impairs hepatic clearance of gut-derived bacterial antigens. The mucosal reticuloendothelial system mounts an intense compensatory polyclonal response dominated by secretory and serum IgA. Because IgA possesses fast electrophoretic mobility, it migrates directly into the beta-gamma interface, creating the classic beta-gamma bridge.

4. Nephrotic Syndrome Pattern

• Densitometric Appearance: Massive collapse of the albumin peak accompanied by profound depletion of transferrin (beta-1), with an enormous, towering Alpha-2 peak that often matches or exceeds the height of the remaining albumin fraction.
• Pathophysiology: Glomerular filtration barrier damage allows massive selective proteinuria (>3.5 g/24 hr). Small proteins (albumin, transferrin) are lost in urine. Hepatocytes dramatically up-regulate protein synthesis, but because Alpha-2-Macroglobulin (720 kDa) is too massive to pass through damaged glomerular pores, it accumulates in serum.

5. Acute-Phase Reactant Pattern (Systemic Inflammation)

• Densitometric Appearance: Mild to moderate decrease in albumin (negative reactant), accompanied by prominent, concurrent elevations in both the Alpha-1 (AAT, AAG) and Alpha-2 (Haptoglobin) bands.
• Pathophysiology: Acute inflammatory cytokine release (IL-1, IL-6, TNF-$\alpha$) during acute bacterial infection, myocardial infarction, acute tissue trauma, extensive burns, or malignancy.

6. Alpha-1-Antitrypsin Deficiency Pattern

• Densitometric Appearance: Severe flattening, scalloping, or total absence of the alpha-1 band, with a direct drop from the albumin slope down to the alpha-2 zone.
• Pathophysiology: Homozygous PiZZ mutation in the SERPINA1 gene preventing hepatic release of AAT.

7. Hypogammaglobulinemia Pattern

• Densitometric Appearance: Profound, flattened depression of the gamma globulin region (<0.4 g/dL).
• Pathophysiology: Congenital primary immunodeficiencies (Bruton X-linked agammaglobulinemia [BTK mutation], Severe Combined Immunodeficiency [SCID], Common Variable Immunodeficiency [CVID]), or acquired secondary suppression (chronic lymphocytic leukemia [CLL], light-chain multiple myeloma, immunosuppressive therapy).

---

Immunofixation Electrophoresis (IFE)

While SPEP detects the presence and location of an abnormal protein band, it cannot identify immunoglobulin class or verify clonality. Immunofixation Electrophoresis (IFE) is the gold standard diagnostic method required to characterize paraproteins.

Immunofixation Electrophoresis (IFE) 6-Lane Setup
Lane:     SP        G         A         M         K         L
       (Total)   (IgG)     (IgA)     (IgM)     (Kappa)   (Lambda)
        ┌───┐
        │   │                                            <- Albumin
        └───┘



                  ┌───┐                           ┌───┐
                  │   │                           │   │  <- Monoclonal Band
                  └───┘                           └───┘     (e.g., IgG Kappa)

Analytical Protocol

1. Parallel Electrophoresis: Patient serum is diluted and applied across six adjacent lanes on an agarose gel. An electrical current is applied, separating the proteins identically across all six lanes.
2. Antisera Overlay: The six lanes are overlaid with specific monospecific liquid antisera:
   • Lane 1 (SP - Serum Protein): Overlaid with a protein fixative (acid) to visualize the reference total protein pattern.
   • Lane 2 (G): Monospecific anti-human IgG heavy chain.
   • Lane 3 (A): Monospecific anti-human IgA heavy chain.
   • Lane 4 (M): Monospecific anti-human IgM heavy chain.
   • Lane 5 (K): Monospecific anti-human Kappa ($\kappa$) light chain (free and bound).
   • Lane 6 (L): Monospecific anti-human Lambda ($\lambda$) light chain (free and bound).
3. Immunoprecipitation and Washing: Wherever antisera encounter matching immunoglobulin chains, insoluble, cross-linked antigen-antibody immune complexes precipitate permanently within the porous agarose gel matrix. The gel is washed extensively with saline and blotted with absorbent paper to completely elute all unprecipitated, soluble non-immune proteins.
4. Staining and Interpretation:
   • The gel is stained with acid violet or Coomassie blue.
   • Monoclonal Paraprotein: Forms a sharp, intensely stained, localized precipitin band that aligns precisely between one heavy-chain lane and one light-chain lane (e.g., a sharp band in Lane G and Lane K at the identical migration distance confirms an IgG $\kappa$ monoclonal gammopathy).
   • Polyclonal Distribution: Appears as a light, diffuse smear across the entire heavy-chain and light-chain tracks without discrete banding.
   • Light-Chain Only Myeloma: Exhibits a sharp band in Lane K or L, with no corresponding band in Lanes G, A, or M (confirming a monoclonal free light chain disorder).

---

Serum Free Light Chains (sFLC) and Bence Jones Proteins

During normal plasma cell antibody synthesis, light chains are produced in slight stoichiometric excess of heavy chains (~500 mg/day of polyclonal free light chains enter circulation). Intact immunoglobulins possess two identical heavy chains and two identical light chains (either $\kappa$ or $\lambda$, never mixed). In malignant plasma cell dyscrasias, excessive uncoupled monoclonal light chains are synthesized and released.

• Serum Free Light Chain (sFLC) Immunoassay: Highly sensitive quantitative nephelometric or turbidimetric assays utilize latex-bound antibodies directed exclusively against epitopes exposed only when light chains are unbound (free), exhibiting zero cross-reactivity with light chains bound to intact immunoglobulins.
  • Normal Reference Interval: Free $\kappa$: 3.3 to 19.4 mg/L; Free $\lambda$: 5.7 to 26.3 mg/L.
  • Diagnostic $\kappa/\lambda$ Ratio: The normal physiological ratio ranges from 0.26 to 1.65 (median ~0.60).
  • Renal Impairment Reference Range: In chronic renal failure, impaired reticuloendothelial clearance extends the normal reference ratio to 0.37 to 3.10.
  • Diagnostic Utility: An abnormal sFLC ratio (<0.26 or >1.65) provides superior clinical sensitivity for detecting Light Chain Multiple Myeloma (LCMM), non-secretory myeloma, and AL (Primary) Amyloidosis, where intact immunoglobulin spikes may be entirely absent on SPEP.
• Bence Jones Proteins (Urinary Light Chains):
  • Free light chains possess a low molecular weight (22 kDa for monomers, 44 kDa for $\lambda$ dimers). Because the glomerular filtration threshold is ~45 to 60 kDa, circulating free light chains are rapidly filtered into the primary urine.
  • At low concentrations, filtered light chains are completely reabsorbed and catabolized by proximal renal tubular epithelial cells. When production exceeds the tubular reabsorption capacity, free light chains spill into urine, designated Bence Jones proteinuria.
  • Classic Heat Precipitation Test: The historical manual screening test demonstrated that Bence Jones proteins precipitate as a white, turbid, flocculent precipitate when heated to 56°C to 60°C, and remarkably redissolve and clear completely when heated to boiling (100°C), reprecipitating upon cooling back to 56°C. Modern clinical laboratories have replaced this manual test with 24-hour Urine Protein Electrophoresis (UPEP) and Urine IFE.

---

Cerebrospinal Fluid (CSF) Electrophoresis and Oligoclonal Bands

Electrophoretic examination of cerebrospinal fluid is performed primarily to evaluate suspected inflammatory and demyelinating central nervous system (CNS) disorders, most notably Multiple Sclerosis (MS).

CSF Oligoclonal Banding Protocol: Intrathecal Synthesis vs. Systemic Leakage

Condition A: True Intrathecal Synthesis (Multiple Sclerosis) -> POSITIVE
  Serum Pattern:  [ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ]  (Normal Polyclonal Smear)
  CSF Pattern:    [ ░░░░░  ||   ||   ||   ░░░░░░░░░░░░░░ ]  (>= 2 Discrete Oligoclonal Bands)

Condition B: Blood-Brain Barrier Breakdown -> NEGATIVE for Intrathecal Synthesis
  Serum Pattern:  [ ░░░░░  ||   ||   ||   ░░░░░░░░░░░░░░ ]  (Identical Systemic Bands)
  CSF Pattern:    [ ░░░░░  ||   ||   ||   ░░░░░░░░░░░░░░ ]  (Passive Transudation into CSF)

Analytical Technique and Clinical Interpretation

• Methodology: High-resolution agarose electrophoresis or Isoelectric Focusing (IEF) on polyacrylamide gels followed by silver staining or sensitive immunoblotting. Because normal CSF total protein is extremely low (15 to 45 mg/dL, <1% of serum concentration), unconcentrated CSF requires high-sensitivity IEF/immunoblotting, or CSF must be concentrated 50- to 100-fold prior to standard agarose electrophoresis.
• Oligoclonal Bands (OCBs): The hallmark diagnostic finding is the presence of two or more discrete, sharp bands in the gamma region of the CSF electrophoretogram that reflect localized, clonal IgG secretion by resident plasma cells in the CNS parenchyma.
• Mandatory Paired Serum Testing: A blood specimen must be collected simultaneously and electrophoresed in an adjacent lane on the same gel. Interpretation requires direct visual comparison:
  • Pattern 1 (Normal): Absence of bands in both CSF and serum.
  • Pattern 2 (Positive for Intrathecal Synthesis): Two or more oligoclonal bands present exclusively in the CSF, with an absence of corresponding bands in the patient's serum. Observed in >90% to 95% of patients with clinically definite Multiple Sclerosis, as well as neurosyphilis, subacute sclerosing panencephalitis (SSPE), and Lyme neuroborreliosis.
  • Pattern 3 (Systemic Gammopathy with BBB Leakage): Identical oligoclonal bands visible in both serum and CSF, reflecting passive transudation of systemic immunoglobulins across a damaged, highly permeable blood-brain barrier (e.g., Guillain-Barré syndrome, systemic vasculitis, metastatic CNS disease) rather than intrathecal synthesis.